Discovery of TQ-3959 as a Potent and Orally Bioavailable BTK PROTAC Degrader Incorporating a Novel Benzisoxazole-Based CRBN Ligand for the Treatment of B-Cell Malignancies
用户-K7WDI05bCT0
6天前
27
10
已完结
1. 当前求助状态已完结, 请及时下载应助文件
2. 系统将在 2025-08-31 09:11:04 删除文件
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规